Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms

J Allergy Clin Immunol. 2008 Mar;121(3):705-9. doi: 10.1016/j.jaci.2007.11.008. Epub 2008 Jan 4.

Abstract

Background: Respiratory symptoms are common in early childhood. The clinical characterization of disease presentation and hence its likely disease progression has so far been proven difficult.

Objective: To investigate whether exhaled nitric oxide (NO) could be helpful to distinguish between subgroups of nonwheezy and wheezy young children less than 4 years of age.

Methods: Exhaled NO was measured in 391 children (age 3-47 months) with nonwheezy and wheezy respiratory symptoms. Children were divided into 3 groups: children with recurrent cough but no history of wheeze (group 1), with early recurrent wheeze and a loose index for the prediction of asthma at school age (group 2), and with frequent recurrent wheeze and a stringent index for the prediction of asthma at school age (group 3).

Results: Children from group 3 showed significantly higher median (interquartile range) fractional exhaled NO (FeNO) levels (11.7 [11.85]) than children from groups 1 (6.5 [5.5]; P < .001) and 2 (6.4 [6.5]; P < .001). No difference in FeNO levels was found between children from groups 1 and 2 (P = .91).

Conclusion: Wheezy young children less than 4 years of age with a stringent index for the prediction of asthma at school age have elevated levels of FeNO compared with children with recurrent wheeze and a loose index for the prediction of asthma at school age or children with recurrent cough.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma*
  • Breath Tests
  • Child, Preschool
  • Cough / physiopathology*
  • Female
  • Humans
  • Hypersensitivity / epidemiology
  • Infant
  • Male
  • Nitric Oxide / analysis*
  • Nitric Oxide / metabolism
  • Respiratory Sounds / physiopathology*
  • Risk Factors

Substances

  • Nitric Oxide